[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fnbT9cQPLXTUzJqjyS4KdGCouVZv_bkpk3pEnmdgKHHc":8,"$fhZ2Gz9w1yoetifGX3H5aI3Q2XkKxK1MoiU1dy1aUpBk":55,"$fYhom3j88ndlbFpTMleL-MLcTMvxNvvRFYwzrBgzQUXA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},55102,863254,[],"https://ystcdn.venuertc.com/medical/ystApp/Dlmj9URvs7gXdepZpARivDbqwZwkg06p.png","朱永亮","龙口南山养生谷肿瘤医院","放射科","住院医师",397,0,"胆管癌晚期用药全指南：化疗、靶向与放疗的安全与实用细节","","https://ystcdn.venuertc.com/venue/AI/af49bc04-c7ed-4cbd-a9f6-803b63cfd6fc.jpg","\u003Cdiv id=\"material_title\" class=\"custom-bileduct-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胆管癌晚期用药全指南：化疗、靶向与放疗的安全与实用细节\u003C/h2>\n  \u003Cp class=\"custom-bileduct-lead\">聊到胆管癌晚期的药物治疗，常见的有吉西他滨、顺铂这样的化疗药，还可能用到一些靶向药、放疗辅助药物。这些药品的使用有不少细节容易被忽视，尤其是在复杂治疗方案下。今天，我们就用通俗语言捋一遍最容易出错、最需要警惕的7个关键用药环节，帮你把握安全用药的每个细节。\u003C/p>\n\u003C/div>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01. 吉西他滨及顺铂联合化疗：操作方法与注意事项\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>给药方式与时间：\u003C/strong>\n      吉西他滨通常静脉输注，给药时间须控制在30分钟内，顺铂则需单独稀释后静脉推注。两者联合时，应遵照医嘱严格先后顺序。\n      \u003Cspan class=\"custom-bileduct-emoji\">⏰\u003C/span>\n      \u003Cbr>\n      \u003Cspan class=\"custom-bileduct-point\">正确做法：\u003C/span> 按照每日或者每周固定位次安排，不得自行调整。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>服药前后饮水：\u003C/strong>\n      顺铂易损伤肾脏，要求在用药前、中、后补充足够水分。\n      \u003Cspan class=\"custom-bileduct-point\">建议：\u003C/span> 使用顺铂当天饮水约2-3升，并严格遵医嘱安排静脉补液，有助于保护肾功能。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>剂量个体化：\u003C/strong>\n      化疗剂量与体表面积和骨髓功能密切相关。\n      \u003Cspan class=\"custom-bileduct-point\">特别提醒：\u003C/span> 有肾功能减退等情况需提前调整剂量。出现白细胞、血小板偏低必须告知医生。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>输注通路选择：\u003C/strong>\n      建议使用中心静脉通路或PICC导管以减少外周静脉刺激与药物渗漏的风险。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>案例说明：\u003C/strong>\n      临床上曾有患者因补水不足使用顺铂后出现肾功能恶化，所以每次足量饮水不要怕麻烦。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02. 靶向药物（例如尼妥珠单抗）：机制与用药禁忌\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>药理作用：\u003C/strong>\n      靶向药如尼妥珠单抗主要针对EGFR（表皮生长因子受体），阻断信号通路，从而抑制异常细胞生长。\n      \u003Cspan class=\"custom-bileduct-emoji\">🎯\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>用药方法：\u003C/strong>\n      采用静脉滴注，首次滴注速度慢，密切观察有无过敏反应。滴注前应采取抗过敏预处理（例如抗组胺药）。\n      \u003Cspan class=\"custom-bileduct-point\">正确做法：\u003C/span> 每周期用量与体重和具体方案相关，绝不可擅自加减量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>禁忌注意：\u003C/strong>\n      有已知EGFR相关严重过敏史者禁用，孕妇、哺乳期妇女慎用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>药物相互作用：\u003C/strong>\n      与免疫抑制剂、某些降压药同用时可能干扰药效。所有慢性药物请提前告知医生。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>典型副作用：\u003C/strong>\n      皮疹、低镁血症较常见，一旦出现皮肤剧烈不适应立即联系专业人员调整治疗。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>案例小结：\u003C/strong>\n      有患者用药后出现面部皮疹，行对症治疗后恢复，日常要注意皮肤卫生。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03. 化疗常见不良反应与管理\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>骨髓抑制：\u003C/strong>\n      吉西他滨、顺铂都可能导致白细胞、血小板下降（骨髓抑制）。\n      \u003Cspan class=\"custom-bileduct-point\">正确做法：\u003C/span> 化疗后定期复查血象，必要时使用升白细胞、升血小板药物。出现感染征兆或出血请及时就医处理。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>恶心呕吐：\u003C/strong>\n      顺铂尤其常见。可预防使用止吐药，饮食选择清淡易消化为主。\u003Cspan class=\"custom-bileduct-emoji\">🤢\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>肾毒性：\u003C/strong>\n      特别与顺铂相关，需足量补液并监测肾功能（肌酐、尿量）。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>疲劳乏力：\u003C/strong>\n      短期内多见，适度活动与保证营养可缓解。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>出现严重不良反应怎么办？\u003C/strong>\n      如高热、寒战、咳嗽、皮疹迅速恶化，建议立即停药并就医。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04. 放疗期间药物辅助用法与管理\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>辅助用药：\u003C/strong>\n      放疗常伴随发热、食欲减退，有时需配合解热镇痛药、胃黏膜保护药等共同应用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>服药顺序：\u003C/strong>\n      放疗期间如需多药并用，务必遵照主治医生建议时间安排。避免同时服用有拮抗作用的药物。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>药物相互作用：\u003C/strong>\n      放射性药物本身与大部分化疗药无直接冲突，但部分辅助药（如激素、抗生素）需间隔使用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>不良反应管理：\u003C/strong>\n      放疗常见消化道反应和局部皮肤并发症。出现皮肤红肿可使用无刺激性乳膏处理。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>案例提示：\u003C/strong>\n      一位患者经历放射性发热，经正确解热药物处理后迅速恢复，切勿自行加用其他药品。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05. 特殊人群和联合用药安全细节\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>老年患者：\u003C/strong>\n      由于肾功能、肝功能下降，要求个体化调整剂量。初用化疗药时先从低剂量起步，根据耐受性缓慢加量。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>高血压或慢病合并症患者：\u003C/strong>\n      化疗期间如需合用降压药、糖尿病药物，一定提前咨询医生调整时间和剂量安排。\u003Cspan class=\"custom-bileduct-emoji\">🩺\u003C/span>\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>肾功能不全：\u003C/strong>\n      使用顺铂时风险更高，必要时选择其他替代药物。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>孕期与哺乳期：\u003C/strong>\n      绝大部分化疗药和靶向药孕期、哺乳期禁用。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>药品联合使用：\u003C/strong>\n      所有中西药联合必须提前让医生掌握全部药物清单，尤其要警惕抗癫痫、防感染、传统中药等潜在干扰。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06. 用药储存、过期处理与遗忘服药如何应对\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      \u003Cstrong>正确储存：\u003C/strong>\n      吉西他滨、顺铂等大多需冷藏（2-8℃）并避光。口服药要密封、远离潮湿和直射光。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>开封后保存：\u003C/strong>\n      化疗药一经启封当天必须用完，不可久置。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>过期药品：\u003C/strong>\n      过期或颜色异常的药品严禁使用，建议按照专用回收渠道处理，不要随意丢弃。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>漏服怎么办？\u003C/strong>\n      单次化疗若误过时间，建议咨询医生调整后续方案。口服辅助药如漏服，下一次用药不应加量补服。\n    \u003C/li>\n    \u003Cli>\n      \u003Cstrong>化疗现场操作：\u003C/strong>\n      药物配制过程严格遵循无菌操作要求，由专业医护人员完成，严禁自行处理药物。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07. 典型用药经验总结🏅\u003C/h2>\n  \u003C/div>\n  \u003Cul class=\"custom-bileduct-list\">\n    \u003Cli>\n      一位中年男性患者，术后接受GP方案化疗三周期，期间合用尼妥珠单抗，出现骨髓抑制，根据血象调整后顺利完成化疗，提示周期性检查血常规是关键；\n    \u003C/li>\n    \u003Cli>\n      放疗辅助期间短暂发热，通过物理降温和规范解热药处理，有效避免多余药物叠加反应，显示放疗配合药物管理要精细；\n    \u003C/li>\n    \u003Cli>\n      日常合用降压药的慢病患者，持续随访血压变化，未发生用药冲突，反映详细汇报既往药史非常必要。\n    \u003C/li>\n  \u003C/ul>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：胆管癌晚期药品使用的安全要诀\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"custom-bileduct-conclusion\">\n    \u003Cp>\n      回头来看，正确处理化疗、靶向药、放疗辅助用药的每个环节，细致关注剂量、用药顺序、反应监测，对保障药效和安全至关重要。出现任何药物副作用或用药疑问，切勿自行处理，首选与医生和药师沟通。各类药品的储存、用量和联用规则，都是有效治疗的基石。合理用药，关注身体变化，及时联系专业人员，为治疗争取最大安全和效果。\n    \u003C/p>\n    \u003Cp>\n      最后，建议将本文推荐的重点细节和家人或照护者分享，让用药安全理念成为全家的共识。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"custom-bileduct-section\">\n  \u003Cdiv class=\"custom-bileduct-bg\">\n    \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">主要参考文献\u003C/h2>\n  \u003C/div>\n  \u003Cdiv class=\"custom-bileduct-reference\">\n    \u003Cul>\n      \u003Cli>\n        National Comprehensive Cancer Network (NCCN). \u003Cem>Hepatobiliary Cancers (Version 2.2023)\u003C/em>. NCCN Clinical Practice Guidelines in Oncology. 2023.\n      \u003C/li>\n      \u003Cli>\n        Valle, J., Wasan, H., Palmer, D.H., et al. (2010). \u003Cem>Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer\u003C/em>. New England Journal of Medicine, 362(14), 1273-1281. https://doi.org/10.1056/NEJMoa0908721\n      \u003C/li>\n      \u003Cli>\n        Van Cutsem, E., et al. (2009). \u003Cem>Epidermal growth factor receptor-targeted therapies in biliary tract cancers: technical and clinical challenges\u003C/em>. Annals of Oncology, 20(9): 1487–1492.\n      \u003C/li>\n      \u003Cli>\n        Kim, R.D., et al. (2022). \u003Cem>Systemic Therapy for Advanced Biliary Tract Cancer: Current Status and Future Perspectives\u003C/em>. Cancers, 14(1), 186.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\n\u003Cstyle>\n/* 统一样式命名空间，避免干扰其他页面 */\n.custom-bileduct-title h1 {\n  font-size: 32px;\n  color: #264653;\n  letter-spacing: 1px;\n  margin-top: 30px;\n  margin-bottom: 10px;\n  text-align: center;\n}\n.custom-bileduct-lead {\n  font-size: 18px;\n  color: #495057;\n  margin-bottom: 35px;\n  text-align: center;\n  max-width: 900px;\n  margin-left: auto;\n  margin-right: auto;\n}\n.custom-bileduct-section {\n  margin: 35px auto 28px auto;\n  max-width: 920px;\n  background: #f7fafb;\n  border-radius: 18px;\n  box-shadow: 0 0 8px rgba(38,70,83,0.05);\n  padding-bottom: 10px;\n}\n.custom-bileduct-bg {\n  background: linear-gradient(120deg, #cce5e3 0%, #e7f2eb 43%, #fff 100%);\n  border-radius: 18px 18px 0 0;\n  padding: 18px 36px;\n}\n.custom-bileduct-bg h2 {\n  color: #277892;\n  font-size: 23px;\n  margin-bottom: 3px;\n  font-weight: bold;\n  letter-spacing: 1px;\n}\n.custom-bileduct-list {\n  list-style: disc inside;\n  margin: 0 35px 0 45px;\n  padding-bottom: 14px;\n}\n.custom-bileduct-list li {\n  font-size: 17px;\n  color: #404a55;\n  margin-bottom: 13px;\n  line-height: 1.9;\n  text-indent: 0em;\n}\n.custom-bileduct-emoji {\n  font-size: 17px;\n  margin-left: 3px;\n  vertical-align: -1px\n}\n.custom-bileduct-point {\n  color: #208a7b;\n  font-weight: bold;\n}\n.custom-bileduct-conclusion {\n  font-size: 17px; \n  color: #254d5f;\n  background: #f5f6fa;\n  border-radius: 0 0 18px 18px;\n  padding: 24px 38px 24px 38px;\n  margin-bottom: 0;\n  margin-top: 0;\n}\n.custom-bileduct-reference {\n  padding: 21px 38px 18px 38px;\n  background: #eef7f5;\n  border-radius: 0 0 18px 18px;\n  margin-bottom: 0px\n}\n.custom-bileduct-reference ul {\n  margin: 0;\n  padding-left: 1.9em;\n}\n.custom-bileduct-reference li {\n  font-size: 16px;\n  color: #384751;\n  margin-bottom: 10px;\n  line-height: 1.7;\n}\n@media (max-width: 720px) {\n  .custom-bileduct-title h1 {\n    font-size: 22px;\n  }\n  .custom-bileduct-lead {\n    font-size: 15px;\n    max-width: 95%;\n  }\n  .custom-bileduct-bg {\n    padding: 14px 14px;\n  }\n  .custom-bileduct-list {\n    margin: 0 12px 0 20px;\n    font-size: 15px;\n  }\n  .custom-bileduct-conclusion, .custom-bileduct-reference {\n    padding-left: 13px;\n    padding-right: 13px;\n    font-size: 15px;\n  }\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"custom-bileduct-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin:",517,"2025-08-04 09:15:14","胆管癌, 化疗药, 靶向药物, 放疗辅助药, 用药安全, 吉西他滨, 顺铂, 尼妥珠单抗, 不良反应, 过期药物处理","了解胆管癌晚期药物治疗的关键要点，包括化疗、靶向药物和放疗应用，确保用药安全与有效性，优化患者护理。阅读后收获丰厚的用药知识！","2025-08-04 14:22:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]